Industry experts from Lachman, Regenxbio, Thermo Fisher Scientific (PPD) and Etena Therapeutics discuss key consideration of successful CGT manufacturing and quality strategies.
Key discussions will include:
Developing a successful regulatory strategy in the evolving CGT field
Achieving CGT quality and compliance through effective quality systems implementation
Navigating increasing CGT manufacturing demand and capacity and scalability challenge
Avoiding quality and compliance issues to ensure patient access